跳到主要导航 跳到搜索 跳到主要内容

CCL13 and human diseases

  • Laifu Li
  • , Fei Dai
  • , Lianli Wang
  • , Yating Sun
  • , Lin Mei
  • , Yan Ran
  • , Fangchen Ye
  • The Second Affiliated Hospital of Xi'an Jiaotong University

科研成果: 期刊稿件 › 文献综述 › 同行评审

56 引用 (Scopus)

摘要

CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many immune cells. Despite extensive research into its function in numerous disorders, a thorough analysis of CCL13 is not yet accessible. The role of CCL13 in human disorders and existing CCL13-focused therapies are outlined in this study. The function of CCL13 in rheumatic diseases, skin conditions, and cancer is comparatively well-established, and some studies also suggest that it may be involved in ocular disorders, orthopedic conditions, nasal polyps, and obesity. We also give an overview of research that found very little evidence of CCL13 in HIV, nephritis, and multiple sclerosis. Even though CCL13-mediated inflammation is frequently linked to disease pathogenesis, it’s fascinating to note that in some conditions, like primary biliary cholangitis (PBC) and suicide, it might even act as a preventative measure.

源语言英语
期刊论文编号1176639
期刊Frontiers in Immunology
卷14
DOI
出版状态已出版 - 2023
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'CCL13 and human diseases' 的科研主题。它们共同构成独一无二的学术指纹。

引用此